Innoviz Technologies Ltd. (INVZ) is a Tel Aviv-based developer of automotive-grade solid-state LiDAR sensors and perception software, sold to automakers and, increasingly, to defense and homeland security customers under its Perciz brand. Shares are trading at $0.1182, down 18.31% from the previous session's close of $0.1447, in a clearly negative move. The immediate cause is verified: late Wednesday the company announced a 1-for-20 reverse share split, the maximum ratio authorized by shareholders, designed to lift the share price back above Nasdaq's $1.00 minimum bid threshold. The stock has now lost roughly two-thirds of its value since mid-September.
Innoviz confirmed that the 1-for-20 split takes effect at 11:59 p.m. Eastern on Friday, December 4, 2026, with split-adjusted trading beginning at the Nasdaq open on Monday, December 7 under the same INVZ symbol and a new CUSIP. Outstanding shares will fall from approximately 299.5 million to roughly 15 million, and authorized share capital will drop from 500 million to 25 million ordinary shares.
The mechanical effect is cosmetic — market capitalization and each holder's percentage ownership are unchanged apart from fractional-share handling. The market reaction, however, reflects what the filing signals. Rather than opting for a smaller ratio, the board selected the maximum 1-for-20 authorized at the September 16 annual general meeting, underscoring the depth of the listing problem. The company also stated plainly that there can be no assurance the split will achieve or sustain compliance, leaving open the possibility of a fresh deficiency notice if the adjusted price slips back below $1.00.
For a heavily shorted, deeply speculative micro-cap, that combination — a maximum-ratio split, an explicit warning, and no operational news attached — is a clear negative signal. Investors have historically treated reverse splits by cash-burning small caps as confirmation of structural weakness rather than a solution.
The split landed on top of an already weakened narrative. On November 11, Innoviz reported third-quarter revenue of $12.1 million, down from $15.3 million a year earlier and well short of consensus, after a customer pushed its start-of-production timeline into 2027 and shifted a large block of engineering revenue with it. Gross margin was negative 10.3%, cash burn accelerated to $21.4 million, and full-year revenue guidance was reset to $44 million–$46 million. Management is cutting roughly 20% of its workforce as part of a realignment targeting about $17.5 million in annualized savings, and ended the quarter with $54.4 million in cash and equivalents and no long-term debt.
Analysts responded within days. JPMorgan downgraded the stock to Neutral from Overweight on November 12, and Goldman Sachs kept a Neutral rating while cutting its target to $0.20 from $0.40 on November 16 — a level the shares have now breached on an adjusted basis. Consensus sits at Hold with an average target near $0.20.
Innoviz opened Thursday at $0.113, briefly touched $0.107, and has since recovered into the $0.11–$0.12 range, but it remains far below the $0.1447 prior close. The stock sits beneath both its 20-day and 60-day moving averages and is pressing against the lower end of its 52-week range, having fallen from about $0.40 in mid-September.
The move is company-specific. LiDAR peers such as MVIS and OUST traded only modestly lower, and broader indices showed no comparable weakness. Volume confirms conviction behind the selling rather than a thin, order-book-driven print, with turnover already exceeding a full average session by early afternoon.
The score runs from 0 — no meaningful news and a routine price move — to 100, meaning transformative news paired with an extreme, rare move. Innoviz lands at 58 out of 100.
The verified news is material but not transformative: a reverse split is a listing-compliance step, not an operating result, though choosing the maximum 1-for-20 ratio and warning about sustained compliance raises its weight relative to a company now worth roughly $35 million. The price action was highly unusual — today's decline of 18.31% is about 4.5 times the stock's average absolute daily move of roughly 4.0% and is larger than any single session in the past 60, with volume amplifying the signal. Moderate news plus a rare move produces the mid-range score.
All attention now shifts to Monday, December 7, when split-adjusted trading begins. Whether the shares hold above $1.00 on that date — theoretically near $2.40 based on current levels — will determine if the compliance issue is resolved or merely deferred, since a sustained sub-$1.00 price would invite another deficiency notice. Investors will also watch for the December quarter's revenue print against the $44 million–$46 million full-year target, progress converting defense and counter-UAS pilots into volume orders expected in the first half of 2027, and whether the 20% workforce reduction delivers the promised savings without disrupting customer programs. The principal risks remain continued cash burn, negative gross margins, NRE timing uncertainty, and the possibility of additional capital raising that would dilute holders already down more than 80% this year.
Tickeron's Trending AI Robots page curates the AI trading bots performing strongest under present market conditions, drawn from a library of hundreds of bots covering thousands of tickers. Each bot differs by strategy, timeframe, performance metrics, and the symbols it trades, so results vary widely across market environments. The trending section narrows that universe to the systems currently generating the most consistent output. Review the live rankings to see which strategies are working right now and how they compare before allocating capital.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
INVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 39 of 42 cases where INVZ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +13.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where INVZ advanced for three days, in 188 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INVZ as a result. In 66 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for INVZ turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 36 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for INVZ entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.285) is normal, around the industry mean (0.781). P/E Ratio (-0.553) is within average values for comparable stocks, (39.881). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.494). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (1.236) is also within normal values, averaging (49.456).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. INVZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INVZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AutoPartsOEM